BeyondSpring BYSI Stock
BeyondSpring Price Chart
BeyondSpring BYSI Financial and Trading Overview
| BeyondSpring stock price | 2.09 USD |
| Previous Close | 0.89 USD |
| Open | 0.86 USD |
| Bid | 0.93 USD x 3000 |
| Ask | 0.97 USD x 800 |
| Day's Range | 0.86 - 0.97 USD |
| 52 Week Range | 0.65 - 3.45 USD |
| Volume | 39.93K USD |
| Avg. Volume | 77.12K USD |
| Market Cap | 36.98M USD |
| Beta (5Y Monthly) | -0.021 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.71 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
BYSI Valuation Measures
| Enterprise Value | 5.3M USD |
| Trailing P/E | N/A |
| Forward P/E | -2.0212765 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 27.37076 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 3.921 |
| Enterprise Value/EBITDA | -0.143 |
Trading Information
BeyondSpring Stock Price History
| Beta (5Y Monthly) | -0.021 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 3.45 USD |
| 52 Week Low | 0.65 USD |
| 50-Day Moving Average | 0.92 USD |
| 200-Day Moving Average | 1.05 USD |
BYSI Share Statistics
| Avg. Volume (3 month) | 77.12K USD |
| Avg. Daily Volume (10-Days) | 25.05K USD |
| Shares Outstanding | 38.92M |
| Float | 23.86M |
| Short Ratio | 53.35 |
| % Held by Insiders | 26.47% |
| % Held by Institutions | 14.56% |
| Shares Short | 2.05M |
| Short % of Float | 8.66% |
| Short % of Shares Outstanding | 5.26% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -2434.22% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -36.40% |
| Return on Equity (ttm) | -310.48% |
Income Statement
| Revenue (ttm) | 1.35M USD |
| Revenue Per Share (ttm) | 0.04 USD |
| Quarterly Revenue Growth (yoy) | -0.10% |
| Gross Profit (ttm) | N/A |
| EBITDA | -37007000 USD |
| Net Income Avi to Common (ttm) | -33279000 USD |
| Diluted EPS (ttm) | -0.85 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 37.27M USD |
| Total Cash Per Share (mrq) | 0.96 USD |
| Total Debt (mrq) | 4.96M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 5.24 |
| Book Value Per Share (mrq) | -0.153 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -27464000 USD |
| Levered Free Cash Flow (ttm) | -26583000 USD |
Profile of BeyondSpring
| Country | United States |
| State | NY |
| City | New York |
| Address | 28 Liberty Street |
| ZIP | 10005 |
| Phone | (646) 305-6387 |
| Website | https://beyondspringpharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 73 |
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and for treatment of later-stage non-small cell lung cancer. It is also developing Plinabulin in combination with various immuno-oncology agents, including nivolumab, a PD-1 antibody for the treatment of non-small cell lung cancer; ipilimumab, a CTLA-4 antibody for the treatment of extensive-stage small cell lung cancer; and in combination with PD-1 or PD-L1 antibodies and radiation for the treatment of various cancers. In addition, the company engages in the development of three small molecule immune agents in preclinical stages; and a drug development platform. The company was founded in 2010 and is headquartered in New York, New York.
Q&A For BeyondSpring Stock
What is a current BYSI stock price?
BeyondSpring BYSI stock price today per share is 2.09 USD.
How to purchase BeyondSpring stock?
You can buy BYSI shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for BeyondSpring?
The stock symbol or ticker of BeyondSpring is BYSI.
Which industry does the BeyondSpring company belong to?
The BeyondSpring industry is Biotechnology.
How many shares does BeyondSpring have in circulation?
The max supply of BeyondSpring shares is 39.02M.
What is BeyondSpring Price to Earnings Ratio (PE Ratio)?
BeyondSpring PE Ratio is now.
What was BeyondSpring earnings per share over the trailing 12 months (TTM)?
BeyondSpring EPS is -0.71 USD over the trailing 12 months.
Which sector does the BeyondSpring company belong to?
The BeyondSpring sector is Healthcare.
BeyondSpring BYSI included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Capital Market Composite RCMP | 114.55 USD — |
-2.27
|
— — | 114.09 USD — | 116.72 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}